LOCUS BD162196 30 bp DNA linear PAT 24-AUG-2012 DEFINITION JP 2002173500-A/3: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer. ACCESSION BD162196 VERSION BD162196.1 KEYWORDS JP 2002173500-A/3. SOURCE synthetic construct ORGANISM synthetic construct other sequences; artificial sequences. REFERENCE 1 (bases 1 to 30) AUTHORS Okano,F. TITLE Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer JOURNAL Patent: JP 2002173500-A 3 21-JUN-2002; TORAY INDUSTRIES INC COMMENT OS Artificial Sequence PN JP 2002173500-A/3 PD 21-JUN-2002 PF 14-MAR-2001 JP 2001072026 PR PA TORAY INDUSTRIES INC PI FUMIYOSHI OKANO PT "Cancer inhibitor, method for enhancing the expression of PT cancer PT inhibitor, and method for inhibiting mammalian cancer" PS PC C07K14/47,A61K38/00,A61P35/00,A61P43/00,C12N15/09//C07K14/ PC 54,C12N5/06, PC (C12N5/06,C12R1:91),A61K37/02,C12N15/00,C12N5/00,(C12N5/ PC 00,C12R1:91) CC Cancer inhibitor, method for enhancing the expression of CC cancer inhibitor, CC and method for inhibiting mammalian cancer FH Key Location/Qualifiers FT source 1..30 FT /organism="Artificial Sequence" FEATURES Location/Qualifiers source 1..30 /mol_type="unassigned DNA" /db_xref="taxon:32630" /organism="synthetic construct" BASE COUNT 9 a 8 c 4 g 9 t ORIGIN 1 aagactctca ttcaagacca tgttctcagt //